Accountability remains with the organization and the humans who approved, owned, and monitored the agent. The agent is a governed actor, not a responsible party. Healthcare teams should make ownership visible, keep audit trails clear, and define escalation paths before the agent is put into production. That is the only way to preserve clinical accountability.
Why This Matters for Security Teams
When an AI agent blocks, delays, or misroutes clinical access, the problem is rarely just a help desk incident. It is an identity and governance failure that can affect patient care, auditability, and regulatory exposure at the same time. The organisation remains accountable, but the control gap often sits in how the agent was approved, what it could reach, and whether anyone could stop it in time. NHI Management Group’s analysis of agent risk shows why this is not theoretical: in the AI Agents: The New Attack Surface report, 80% of organisations said their AI agents had already acted beyond intended scope.
That matters in clinical environments because agents are autonomous, goal-driven workloads, not static users. They can chain tools, act on stale context, and trigger access paths that no human reviewer anticipated. This is why current guidance from OWASP Agentic AI Top 10 and NIST AI Risk Management Framework keeps returning to governance, traceability, and runtime control rather than trust in the model alone. In practice, many security teams encounter access failures only after the agent has already interrupted a clinician’s workflow, rather than through intentional testing.
How It Works in Practice
The safest operating model is to treat the agent as a governed workload identity, not as a standing user. That means the agent should authenticate with a workload identity primitive, then receive only the minimum privilege needed for the specific task, for the shortest useful period. Static RBAC alone is weak here because an autonomous agent does not have a stable access pattern. Its intent changes by prompt, tool call, and environmental context, so authorisation should be evaluated at request time.
Best practice is evolving toward intent-based or context-aware authorisation, where policy checks answer: what is the agent trying to do, on whose behalf, against which system, and with what confidence? In clinical settings, that usually means combining policy-as-code with just-in-time credentials, short-lived secrets, and clear revocation when the task ends. This is where CSA MAESTRO agentic AI threat modeling framework and OWASP Non-Human Identity Top 10 are useful: they push teams to define identity, privilege, secret handling, and audit boundaries before production.
- Issue per-task access with JIT provisioning rather than persistent credentials.
- Bind the agent to a workload identity and log every tool invocation.
- Gate sensitive actions on runtime policy, not only on pre-approved roles.
- Separate approval authority from execution authority so clinical owners stay in control.
When organisations ignore this model, they often see the same pattern repeated: the agent inherits access too broadly, a workflow change expands its reach, and no one can quickly prove what it touched or why. These controls tend to break down in highly integrated hospital environments because legacy EHR interfaces, shared service accounts, and emergency access paths make fine-grained runtime policy difficult to enforce.
Common Variations and Edge Cases
Tighter access controls often increase operational overhead, requiring organisations to balance clinical availability against security precision. That tradeoff is real in emergency care, call-centre triage, and after-hours support, where a blocked agent can slow legitimate work. There is no universal standard for this yet, but the direction is consistent: keep standing privilege low, and widen access only when a named human owner accepts the risk.
Edge cases usually arise when agents act across multiple systems or when they delegate to other agents. In those environments, accountability should be documented at the owning team level, with escalation paths, break-glass procedures, and periodic review of access logs. The NIST AI Risk Management Framework is useful for this governance layer, while OWASP NHI Top 10 helps teams map credential misuse, over-privilege, and weak auditability to concrete controls.
Where secrets remain long-lived or shared across workflows, the accountability model becomes harder to defend because the line between agent error, human approval, and platform failure gets blurred. Current guidance suggests using short-lived credentials, explicit task scoping, and human approval for irreversible actions, especially when the agent can reach patient records or operational systems. For teams studying real compromise patterns, AI LLM hijack breach and 52 NHI Breaches Analysis show how quickly uncontrolled access turns into a governance problem, not just a technical one.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Agentic AI Top 10 and CSA MAESTRO address the attack and risk surface, while NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Agentic AI Top 10 | A1 | Agentic risk controls address autonomous access and unsafe actions. |
| CSA MAESTRO | Maps threat modeling to autonomous agent identity and execution authority. | |
| NIST AI RMF | AI RMF governance functions fit accountability for clinical agent failures. |
Define runtime guardrails and approval gates for every agent action that can affect clinical access.
